Get startedLog in
    Picture of Evelo Biosciences logo

    EVLO — Evelo Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Evelo Biosciences Treats First Patients In Phase 2 Dose-Ranging Trial Of EDP1815 For Treatment Of Psoriasis

    Picture of Evelo Biosciences logoEvelo Biosciences
    13/10/2020 12:35
    Oct 13 (Reuters) - Evelo Biosciences Inc  EVLO.O :
    * EVELO BIOSCIENCES TREATS FIRST PATIENTS IN PHASE 2
DOSE-RANGING
TRIAL OF EDP1815 FOR TREATMENT OF PSORIASIS
    * EVELO BIOSCIENCES INC - INTERIM DATA FROM STUDY IS
EXPECTED BY
MID-2021

Source text for Eikon:  ID:nGNE9xkn8L 
Further company coverage:  EVLO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Evelo Biosciences

    See all news